Skip to content
AwardedSpainGoods€6,909,091

CBAM 765/2022 ABBOTT LABORATORIES/08

Published
Published 13 July 2026

Overview

Servicio Andaluz de Salud has awarded Abbott Laboratories, S.A. a contract valued at €6,909,090.91 for the supply of flash glucose monitoring systems for interstitial glucose (MFG) for pediatric and adult patients with type 1 diabetes, type 2 diabetes requiring intensive insulin therapy, and other insulin-dependent diabetes conditions. The award was made on 14 May 2026 under a framework agreement establishing successive supply and unit pricing terms.

Key details

Country
Spain
Status
Awarded
Category
Goods
Estimated value
€6,909,091
Procedure
Direct
Published
13 July 2026
Classification (CPV)
Medical equipmentsPharmaceutical products

Award outcome

Awarded value
€6,909,091
Award date
14 May 2026
Contract period
— → 13 November 2026
Winner
  • ABBOTT LABORATORIES, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    13 July 2026

Contracting authority

  • Servicio Andaluz de Salud. Hospital Universitario de Málaga

    Procuring entity

    Málaga, Spain

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: CBAM 765/2022 ABBOTT LABORATORIES/08 — won by ABBOTT LABORATORIES, S.A. — Skim